Literature DB >> 8484065

[Cytogenetic study of 22 adults and 3 children with acute lymphoblastic leukemia].

R M Arana-Trejo1, A Cervantes-Peredo, E Rozen, J J Kassack, M Gutiérrez, S Kofman-Alfaro.   

Abstract

Between 1987 and 1990 cytogenetic studies of bone marrow and lymphocytes from peripheral blood from 25 patients with de novo ALL were performed. All cases had chromosomal aberrations; however in 23 patients a normal cell line was also present. The most important structural aberrations found were: t(17;19)(q11;p13), t(2;9;22)(q34;q34;11), t(1;7)(p13;q33), t(6;11)(q26;p16), t(3;4)(q24-25;q26), t(1;12)(q23;q34), t(2;18)(q15;p12), t(2;4)(q23;q35) and t(4;11)(q21;q23). These chromosome abnormalities correlate with the response to treatment and survival and improve the identification of high-risk patients. Our study shows the presence of some chromosomal abnormalities different to those reported in the literature; however the breakpoints involved seem to be the same which suggests that these critical regions may be directly involved in the pathogenesis of these disorders.

Entities:  

Mesh:

Year:  1993        PMID: 8484065

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  3 in total

1.  BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Authors:  Karen A Dun; Rob Vanhaeften; Tracey J Batt; Louise A Riley; Giuseppe Diano; Jan Williamson
Journal:  Blood Adv       Date:  2016-11-30

2.  Clinical implications of cytogenetic classification in adult acute lymphoblastic leukaemia patients.

Authors:  R Ankathil; N Geetha; P Remani; V P Gangadharan; G R Pillai; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  A rare variant of t(17;19) in a case of Philadelphia positive adult acute lymphoblastic leukemia presenting with disseminated intravascular coagulation.

Authors:  Moeinadin Safavi; Akbar Safaei; Mahnaz Lotfi
Journal:  Blood Res       Date:  2018-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.